Published in Int J Epidemiol on June 01, 1986
Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase. World J Gastroenterol (2014) 0.82
Social Disparities in Exposure to Point-of-Sale Cigarette Marketing. Int J Environ Res Public Health (2016) 0.75
Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol (1971) 1.42
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am J Epidemiol (1965) 1.24
Recovery from primary infection with Langat E5 virus in normal and cyclophosphamide treated mice: relative roles of virus multiplication, interferon, antibody and serum protective factor. Am J Epidemiol (1969) 1.14
The effect of cyclophosphamide treatment on experimental arbovirus infections. Am J Epidemiol (1969) 1.11
Gastrointestinal cancer mortality in New Jersey counties, and the relationship with environmental variables. Int J Epidemiol (1983) 1.09
Role of serum protective factor (SPF) in Langat virus infection of neonatally thymectomized, cyclophosphamide-treated, or antilymphocyte-treated mice. J Immunol (1969) 1.05
Acute myocardial infarction in Newark, N.J. A study of racial incidence. Arch Intern Med (1977) 1.05
Cross-protection with group B arboviruses in mice treated with cyclophosphamide: role of serum antibody, viremia, and virus multiplication in the brain. Am J Epidemiol (1969) 1.04
Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am J Epidemiol (1966) 1.02
A chick embryo attenuated strain (TP21 E5) of Langat virus. I. Virulence of the virus for mice and monkeys. Am J Epidemiol (1966) 1.00
Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. Am J Epidemiol (1968) 0.98
Vaccination of human volunteers against Russian spring-summer (RSS) virus complex with attenuated Langat E5 virus. Bull World Health Organ (1970) 0.95
Carcinoma of the cervix in Newark, New Jersey, 1970-76. A very low in situ: invasive ratio. J Reprod Med (1981) 0.93
Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses. Am J Epidemiol (1967) 0.92
A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon. Am J Epidemiol (1967) 0.91
Life time occupation, smoking, caffeine, saccharine, hair dyes and bladder carcinogenesis. Int J Epidemiol (1982) 0.90
A chick embryo attenuated strain (TP21 E5) of Langat virus. II. Stability after passage in various laboratory animals and tissue cultures. Am J Epidemiol (1966) 0.89
The mechanism of cross-protection afforded by dengue virus against West Nile virus in hamsters. J Hyg (Lond) (1972) 0.89
A chick embryo attenuated strain (TP21 E5) of Langat virus. 3. The ability to protect against homologous virus and Powassan virus in cross-challenge experiments. Am J Epidemiol (1966) 0.88
Maternal and cord blood metal concentrations and low birth weight--a case-control study. Am J Clin Nutr (1978) 0.87
Plasma concentrations of calcium, chromium, copper, iron, magnesium, and zinc in maternal and cord blood and their relationship to low birth weight. J Lab Clin Med (1978) 0.86
Composition of tobaccos from countries with high and low incidences of lung cancer. I. Selenium, polonium-210, Alternaria, tar, and nicotine. J Natl Cancer Inst (1981) 0.84
Immunization of mice against Russian spring-summer virus complex and monkeys against Powassan virus with attenuated Langat E5 virus. Duration of protection. Am J Trop Med Hyg (1973) 0.84
Role of serum protective factor and neutralizing antibody in pathogenesis of experimental infection with Langat virus in mice. J Infect Dis (1970) 0.84
Vitamin levels in low-birth-weight newborn infants and their mothers. Am J Obstet Gynecol (1977) 0.83
Cancer among blacks in Newark, New Jersey, 1970-1976: a national and international comparison. Cancer (1982) 0.82
Lead content of tissues of baby rats born of, and nourished by lead-poisoned mothers. J Lab Clin Med (1976) 0.80
A new specific humoral viral resistance factor, serum protective factor--some biologic and physical properties. J Immunol (1971) 0.79
Potentiation of the neurovirulence of langat virus infection by lead intoxication in mice. Exp Mol Pathol (1978) 0.79
Vitamin profiles in elderly persons living at home or in nursing homes, versus profile in healthy young subjects. J Am Geriatr Soc (1979) 0.78
Attenuated Langat E5 virus as a live virus vaccine against Kyasanur Forest disease virus. Indian J Med Res (1981) 0.78
The attenuation of the 26th mouse brain passage of New Guinea C strain of dengue 2 virus for use in the sequential immunization procedure against group B arboviruses. Am J Trop Med Hyg (1973) 0.77
Control of hepatitis B infection. The role of surveillance and an isolation hemodialysis center. JAMA (1981) 0.76
Intake of magnesium and toxicity of lead: an experimental model. Arch Environ Health (1979) 0.76
Potentiation of langat virus infection by lead intoxication--influence on host defenses. Acta Virol (1977) 0.76
Emetine-induced cardiomyopathy in rabbits. J Submicrosc Cytol (1983) 0.75
Signification of high density and total cholesterol and triglycerides in acute myocardial infarction -- a case-control study. Clin Biochem (1981) 0.75
Infant mortality in Newark, New Jersey. A study of sociodemographic and medical factors. Public Health Rep (1979) 0.75
Live and inactivated vaccines of group B arboviruses: role of neutralizing antibody and serum protective factor. Nature (1969) 0.75
Central tumor registry--an overview. J Med Soc N J (1975) 0.75
Serum protective factor: an antiviral humoral substance produced in vivo--identification and mechanism of action. Ann N Y Acad Sci (1977) 0.75
Evaluation of hospital and commercial toxic screens. J Med Soc N J (1983) 0.75
Passive transfer of acquired resistance in mice to group B Arboviruses by serum protective factor(s) (SPF) independent of serum neutralizing antibody or interferon. Am J Epidemiol (1968) 0.75
Melanoma of the skin in New Jersey. J Med Soc N J (1978) 0.75
Epidemiologic and histologic patterns of Hodgkin's disease in blacks. Cancer (1977) 0.75
Geographic variations in coronary heart disease. A perspective on risk factors and prevention. Adv Myocardiol (1980) 0.75
Primary and secondary prevention among adults: an analysis with comments on screening and health education. Prev Med (1976) 0.75
Trends in cancer mortality in New Jersey--comparison of geographic distribution in 1950-1969 and 1969-1975. J Med Soc N J (1981) 0.75
Automobile accidents--seat belts and air bags. N J Med (1986) 0.75
Epidemiology of schizophrenia. Public Health Rev (1982) 0.75
Cancer incidence and mortality in Newark, N. J. 1970-1974: a national comparison. Cancer (1981) 0.75
Comparative evaluation of two lots of Wister RA 27/3 rubella virus vaccine in young children. J Hyg Epidemiol Microbiol Immunol (1980) 0.75